Virtu Financial LLC Chemo Centryx, Inc. Transaction History

Virtu Financial LLC

  • $1.82 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 07, 2022
BUY
$22.17 - $51.8 $460,382 - $1.08 Million
20,766 New
20,766 $1.07 Million
Q3 2021

Nov 12, 2021
SELL
$13.18 - $19.83 $612,382 - $921,361
-46,463 Closed
0 $0
Q2 2021

Sep 17, 2021
BUY
$9.59 - $50.88 $445,580 - $2.36 Million
46,463 New
46,463 $622,000
Q3 2020

Dec 11, 2020
SELL
$46.35 - $61.69 $308,273 - $410,300
-6,651 Closed
0 $0
Q2 2020

Aug 07, 2020
BUY
$38.58 - $65.07 $256,595 - $432,780
6,651 New
6,651 $383,000

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email